These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10911522)

  • 1. Recovery of fosphenytoin injection after simulated nasogastric administration.
    Evans JL; Roby CA; Burstein AH
    Am J Health Syst Pharm; 2000 Jun; 57(12):1180. PubMed ID: 10911522
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays.
    Kugler AR; Annesley TM; Nordblom GD; Koup JR; Olson SC
    Clin Chem; 1998 Jul; 44(7):1474-80. PubMed ID: 9665426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats.
    Burstein AH; Cox DS; Mistry B; Eddington ND
    Epilepsy Res; 1999 Apr; 34(2-3):129-33. PubMed ID: 10210027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosphenytoin injection introduced as replacement for Dilantin injection.
    Am J Health Syst Pharm; 1996 Oct; 53(19):2249. PubMed ID: 8893059
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of therapeutic plasma exchange on phenytoin plasma concentration in patients receiving intravenous fosphenytoin therapy.
    Nishida S; Hayashi Y; Hirai K; Takekoshi A; Yamada Y; Kobayashi R; Shimizu S; Niwa T; Hayashi H; Shimohata T; Sugiyama T; Suzuki A
    Pharmazie; 2020 Oct; 75(10):488-490. PubMed ID: 33305722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosphenytoin in infants.
    Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS
    J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate fosphenytoin use in the ED.
    Johnson J; Wrenn K
    Am J Emerg Med; 2001 Jul; 19(4):293-4. PubMed ID: 11447516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosphenytoin facts.
    Chioffi SM; Lassiter TF; Scates AC; McLendon BM
    Am J Nurs; 1999 Aug; 99(8):14. PubMed ID: 10456012
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenytoin and fosphenytoin: a model of cost and clinical outcomes.
    Armstrong EP; Sauer KA; Downey MJ
    Pharmacotherapy; 1999 Jul; 19(7):844-53. PubMed ID: 10417033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
    Fischer JH; Cwik MJ; Luer MS; Sibley CB; Deyo KL
    Ann Pharmacother; 1997 May; 31(5):553-9. PubMed ID: 9161647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin.
    Keegan MT; Bondy LR; Blackshear JL; Lanier WL
    Mayo Clin Proc; 2002 Jun; 77(6):584-6. PubMed ID: 12059129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on fosphenytoin (Cerebyx) dosing.
    Pruitt AC
    J Emerg Nurs; 1998 Feb; 24(1):6-7. PubMed ID: 9534521
    [No Abstract]   [Full Text] [Related]  

  • 14. Fosphenytoin and status epilepticus.
    Brown J
    Hosp Med; 1999 Jan; 60(1):70-1. PubMed ID: 10197108
    [No Abstract]   [Full Text] [Related]  

  • 15. Time-Dependent Decline in Serum Phenytoin Concentration With Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study.
    Ohno Y; Niwa T; Hirai K; Suzuki K; Yamada Y; Hayashi Y; Hayashi H; Suzuki A; Itoh Y
    Ther Drug Monit; 2018 Aug; 40(4):507-511. PubMed ID: 29683874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administer single-site 30-mL intramuscular injection?
    Harrington L
    Medsurg Nurs; 2005 Dec; 14(6):379-82. PubMed ID: 16447828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of parenteral antiepileptic drugs and the role for fosphenytoin.
    Wilder BJ
    Neurology; 1996 Jun; 46(6 Suppl 1):S1-2. PubMed ID: 8649607
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.
    Muchohi SN; Kokwaro GO; Maitho TE; Munenge RW; Watkins WM; Edwards G
    Eur J Drug Metab Pharmacokinet; 2002; 27(2):83-9. PubMed ID: 12064376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of nasogastric administration methods for phenytoin.
    Cacek AT; DeVito JM; Koonce JR
    Am J Hosp Pharm; 1986 Mar; 43(3):689-92. PubMed ID: 3706323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data vs opinion, phenytoin vs fosphenytoin: the saga continues.
    Labiner DM
    Arch Intern Med; 1999 Dec 13-27; 159(22):2631-2. PubMed ID: 10597752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.